Latest France News

Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.

Brazilian Rare Earths Limited has inked a decade-long heavy rare earths offtake deal with Carester and announced a major maiden resource at its Amargosa bauxite project, backed by a $120 million capital raise to accelerate development.

Atlas Arteria reported a robust 10.9% increase in Q3 2025 toll revenue, driven by strong traffic growth across its global portfolio and strategic toll hikes. The company also appointed Kara Lawrence as CEO of Dulles Greenway, signaling a new leadership phase.

Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.

Vulcan Energy has locked in a binding lithium hydroxide supply agreement with Glencore, completing the key offtake contracts needed to finance its Phase One Lionheart Project. This milestone positions Vulcan to advance construction and meet growing European EV battery demand.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.

Brazilian Rare Earths has secured a decade-long heavy rare earth offtake deal with Carester, aligning Brazil’s high-grade resources with a leading European separation facility. This partnership also includes engineering support to accelerate BRE’s refinery development.

CLINUVEL Pharmaceuticals has presented compelling new case studies demonstrating the efficacy of SCENESSE® in treating vitiligo, showing significant and stable repigmentation in patients. These findings, shared at the EADV conference, hint at a potential breakthrough for a condition with limited treatment options.

Atlas Arteria has announced a 20.0 cents per stapled security distribution for the first half of 2025, with payments scheduled for early October. The distribution reflects the company’s ongoing commitment to delivering steady returns from its international toll road assets.

Paladin Energy Ltd has launched a significant A$300 million underwritten equity raising to advance its Patterson Lake South uranium project and support the ramp-up of its Langer Heinrich Mine, reinforcing its position in the global uranium market.